Raynaud’s disease is diagnosed primarily through your description of symptoms and a clinical interview, not a single definitive lab test. A doctor will ask specific questions about how your fingers respond to cold, look for characteristic color changes, and then run blood work to determine whether your Raynaud’s is a standalone condition or a sign of something deeper. Here’s what to expect from that process.
The Three Screening Questions
The core of a Raynaud’s diagnosis is surprisingly simple. An international consensus panel established that clinicians should ask three questions: Are your fingers unusually sensitive to cold? Do your fingers change color when exposed to cold temperatures? Do they turn white, blue, or both? A positive answer to all three confirms a Raynaud’s diagnosis.
What doctors are looking for is the hallmark pattern of digital ischemia, meaning your fingers temporarily lose their blood supply in response to cold. This produces a characteristic sequence of color changes. First, the fingertips turn white as blood flow constricts. Then they turn blue from lack of oxygen. Finally, they flush red as blood returns. This white-blue-red progression is called a “triphasic” response. You don’t need all three colors for a diagnosis. The expert consensus is that at least two color phases are required, and white (pallor) and blue (cyanosis) are considered the two most important. Cold temperatures must be one of your triggers.
The severity grading adds more nuance. If you only experience one color change, your case is considered “possible” Raynaud’s. Repeated episodes with at least two color changes qualify as “definite.” If those biphasic episodes also come with numbness or tingling and happen even in normal temperatures, that’s classified as severe. Attacks themselves can last anywhere from 30 seconds to more than five minutes.
Tracking Your Symptoms Before Your Visit
Because attacks are unpredictable and often happen outside a doctor’s office, documenting them is valuable. If you can photograph your fingers during an episode showing the color changes, that gives your doctor direct visual evidence. Many clinicians also use a tool called the Raynaud’s Condition Score, an 11-point scale where you rate your daily difficulty from 0 (no difficulty) to 10 (extreme difficulty). You consider the number and duration of attacks, symptoms like pain, numbness, burning, and tingling, and how much the condition affects your ability to use your hands. Keeping a brief daily log like this for a couple of weeks before your appointment gives your doctor a much clearer picture than trying to recall episodes from memory.
Blood Tests to Rule Out Underlying Conditions
Once Raynaud’s itself is confirmed, the next step is figuring out whether it’s primary (happening on its own) or secondary (caused by an autoimmune or connective tissue disease like scleroderma or lupus). This distinction matters because secondary Raynaud’s can signal a condition that needs its own treatment.
The most important blood test is the antinuclear antibody (ANA) test, which checks for proteins your immune system produces when it mistakenly attacks your own tissues. A positive ANA doesn’t automatically mean you have an autoimmune disease, but it raises the suspicion enough to warrant further investigation. Your doctor may also order tests for more specific antibodies, including extractable nuclear antigens (ENA), anti-double-stranded DNA, and antiphospholipid antibodies. These help narrow down which autoimmune condition, if any, might be involved.
Inflammatory markers like erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are commonly checked as well. These measure general inflammation in your body. Neither can diagnose a specific disease on its own, and it’s possible to have an inflammatory condition with normal results on both. That’s why they’re typically ordered together and interpreted alongside the rest of your bloodwork. A complete blood count, thyroid function, and kidney function tests round out the standard panel. Primary Raynaud’s patients generally have normal results across all of these tests.
The Cold Stimulation Test
Some vascular specialists use a cold stimulation test to observe your response under controlled conditions. In a standardized version of this test, you immerse both hands in water cooled to about 10°C (50°F) for five minutes. The doctor then monitors how your skin temperature recovers, either through infrared thermography or laser Doppler flowmetry, a technique that measures blood flow in your fingertips in real time. Slower recovery suggests impaired circulation consistent with Raynaud’s.
This test isn’t required for diagnosis in most cases, and not every clinic offers it. It’s more commonly used in research settings or when symptoms are ambiguous. If you’re scheduled for vascular testing, you’ll likely be asked to avoid caffeine and cold medications containing pseudoephedrine beforehand, since both can constrict blood vessels and skew results. Beta-blockers can also affect the test, though you should not stop any prescribed medication without your doctor’s guidance.
Nailfold Capillaroscopy
This is a painless exam where a doctor uses a specialized microscope or magnifying device to look at the tiny blood vessels (capillaries) at the base of your fingernails. In secondary Raynaud’s linked to scleroderma, these capillaries often show distinct abnormalities: enlarged or giant loops, areas where capillaries have disappeared entirely (called rarefaction), tiny hemorrhages, and unusual new vessel growth.
Capillaroscopy has traditionally been considered one of the key tools for telling primary and secondary Raynaud’s apart. However, a 2024 study in Expert Review of Clinical Immunology found that these patterns had lower discriminatory power than previously believed, and on their own could not reliably distinguish primary from secondary Raynaud’s or predict which patients would go on to develop scleroderma. The test is still useful as one piece of the puzzle, but it’s interpreted alongside your bloodwork and clinical history rather than as a standalone answer.
What Primary vs. Secondary Means for You
About 80 to 90 percent of people with Raynaud’s have the primary form, which typically appears between ages 15 and 30, affects both hands symmetrically, and doesn’t progress to tissue damage. Primary Raynaud’s is a diagnosis of exclusion: your symptoms fit, but your blood tests, capillaroscopy, and physical exam don’t turn up any underlying disease.
Secondary Raynaud’s tends to start later in life, may affect one hand more than the other, and can be more severe. Attacks may cause skin ulcers or sores on the fingertips. If your ANA is positive, your capillaroscopy shows abnormalities, or you have other symptoms like joint pain, skin thickening, or persistent fatigue, your doctor will likely refer you to a rheumatologist for further evaluation. The goal isn’t just to manage the Raynaud’s at that point but to identify and treat the condition driving it.
If your initial workup comes back normal but your symptoms are significant, your doctor may recommend repeating bloodwork after 6 to 12 months. A small percentage of people initially diagnosed with primary Raynaud’s eventually develop autoimmune markers, so periodic monitoring is a reasonable precaution, especially in the first few years after diagnosis.